Plixorafenib (FORE 8394; PLX8394) with or without cobicistat (Tybost) demonstrated a clinical benefit and differentiated duration of response in patients with MAPK inhibitor-naive thyroid cancer ...

Thyroid cancer is among the fastest-growing cancers worldwide, yet in many cases, it manifests silently without obvious ...

Navigating Key Endpoints in Oncology Clinical Trials Here's a guide to understanding endpoints you will likely encounter in cancer clinical trials. Medscape Medical News, October 18, 2023 ESMO 2023 ...

ATA 2023 Hold Blood Thinners During Thyroid Nodule Biopsy? No significant differences in nondiagnostic results or hematomas seen when the blood thinners are continued, while discontinuing the ...

Efficacy and Tolerability of a Low-Dose Continuous Regimen of Regorafenib in Refractory Synovial Sarcomas: A Single-Arm, Phase II Trial From India We conducted whole-exome sequencing on 100 (N = 100) ...